Itraconazol Generis

Itraconazole, the active ingredient in Itraconazol Generis, is an azole antifungal presented as an oral formulation for oral use. It treats systemic fungal infections such as aspergillosis, candidiasis, histoplasmosis, blastomycosis and sporotrichosis in adult patients.

GNH USA supplies Itraconazol Generis as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Itraconazole is used to treat fungal infections that involve the systemic or mucosal pathways.

- Aspergillosis: effective in treating invasive disease caused by Aspergillus species. - Candidiasis (oropharyngeal and esophageal): clears infection and relieves symptoms. - Histoplasmosis: controls disseminated infection and prevents progression. - Blastomycosis: eradicates Blastomyces dermatitidis infection. - Sporotrichosis: resolves cutaneous and disseminated disease.

Common side effects are generally mild and reversible.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Rash: skin irritation or mild erythema.

Serious or Rare Side Effects: - Hepatic toxicity: elevated liver enzymes or hepatitis. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Congestive heart failure: fluid retention and reduced cardiac function. - Arrhythmias: irregular heart rhythms. - Visual disturbances: blurred vision or photophobia. - Severe hypotension: sudden drop in blood pressure.

Before initiating therapy, consider the following safety measures.

- Liver function monitoring: assess hepatic enzymes before and during treatment. - Drug interactions: review concomitant medications that affect CYP3A4 metabolism. - Cardiac assessment: avoid use in patients with existing heart failure. - Pregnancy and lactation: prescribe only when benefit outweighs potential risk; safety data are limited. - Renal impairment: adjust dosing in severe renal dysfunction. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture.

Itraconazole has several notable drug interactions that require attention.

Major Interactions (Avoid): - Rifampin: strong enzyme inducer that markedly reduces itraconazole exposure. - Ketoconazole: competitive inhibition may increase itraconazole toxicity. - St. John’s wort: potent CYP3A4 inducer that lowers therapeutic effectiveness.

Moderate Interactions (Monitor Closely): - Calcium channel blockers (e.g., amlodipine): may raise plasma concentrations of itraconazole. - Statins (e.g., simvastatin): increased risk of myopathy; monitor dosage and symptoms. - Proton pump inhibitors: can decrease itraconazole absorption; observe clinical response.